Sort   by:  
 Page size 
TranscriptomicsTasquinimod, a Quinoline-3-Carboxamide Anti-Angiogenic Agent, treated Prostate Cancer Cell Line in-vivo and in-vitro
The quinoline-3-carboxamide ABR-215050 (Tasquinimod (INN)), exhibits anti-tumor activity via inhibition of tumor angiogenesis in human and rodent tumors. To further explore the mode of action of ABR-215050, in vivo experiments with gene microarray analysis were performed using samples of LNCaP prost...
ORGANISM(S): Homo sapiens 
2011-03-01 | E-GEOD-17031 | biostudies-arrayexpress
UnknownSPP1/osteopontin: a driver of fibrosis and inflammation in degenerative ascending aortic aneurysm?
Not available
S-EPMC10560177 | biostudies-literature
GenomicsNBS
WTCCC2 project samples from National Blood Donors (NBS) Cohort
EGAD00000000023 | EGA
GenomicsNBS
WTCCC2 project samples from National Blood Donors (NBS) Cohort
EGAD00000000024 | EGA
ProteomicsProteogenomics of High hyperdiploid childhood acute lymphoblastic leukemia
Proteogenomic analysis and genomic profiling, RNA-sequencing, and mass spectrometry-based analysis of High hyperdiploid childhood acute lymphoblastic leukemia.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2020-01-29 | MSV000084862 | MassIVE
Genomics58C
WTCCC2 project samples from 1958 British Birth Cohort
EGAD00000000021 | EGA
Genomics58C
WTCCC2 project samples from 1958 British Birth Cohort
EGAD00000000022 | EGA
GenomicsMS
WTCCC2 project Multiple Sclerosis (MS) samples
EGAD00000000120 | EGA
GenomicsThe Genetic Analysis of multiple sclerosis
We created these data in order to identify genetic variants associated with increased susceptibility to multiple sclerosis. Cases from many parts of the world were genotyped with the Illumina 660 chip along with Swedish controls. In our analysis we also used control data from the WTCCC2 common UK co...
EGAS00000000101 | EGA
GenomicsWellcome Trust Sanger Institute
Wellcome Trust Sanger Institute
EGAC00001000205 | EGA
Sort   by:  
 Page size